Media
Focus on the development of new antibody drugs for the treatment of tumors and autoimmune inflammatory diseases

Media

新闻动态
Homepage
/
News
/
Press Release
/
Nov.26th, 2018 Kanova had obtained A round of financing with 115 million yuan (RMB)

Nov.26th, 2018 Kanova had obtained A round of financing with 115 million yuan (RMB)

  • Categories:Press Release
  • Author:
  • Origin:
  • Time of issue:2020-01-08 13:51
  • Views:

(Summary description)Nov.26th, 2018 Kanova had obtained A round of financing with 115 million yuan (RMB)

Nov.26th, 2018 Kanova had obtained A round of financing with 115 million yuan (RMB)

(Summary description)Nov.26th, 2018 Kanova had obtained A round of financing with 115 million yuan (RMB)

  • Categories:Press Release
  • Author:
  • Origin:
  • Time of issue:2020-01-08 13:51
  • Views:
Information

Nov.26th, 2018 Kanova had obtained A round of financing with 115 million yuan (RMB)

Scan the QR code to read on your phone

Previous: Feb.19th, 2020 The IND application of “Recombinant anti-human IL-17A / F humanized monoclonal antibody injection” is approved by NMPA.
Next: None
Previous: Feb.19th, 2020 The IND application of “Recombinant anti-human IL-17A / F humanized monoclonal antibody injection” is approved by NMPA.
Next: None
这是描述信息

Add

Zhong Guancun Biopharmaceutical Park, NO.5 Kaituo Road,

Haidian District, Beijing City, China, 10084

A1 Northern Building, 218 Xinghu St. Suzhou Industrial Park, Jiangsu Province, China, 215123

COPYRIGHT @2020 Suzhou xinkanghe Biomedical Technology Co., Ltd   苏ICP备19068714号-1   Power by 300.cn Beijing

这是描述信息

Follow us